Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

doi:10.1084/jem.178.6.2123

This Article

Full Text (PDF, 752K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Secrist, H.

Articles by Umetsu, D. T.

Search for Related Content

PubMed

PubMed Citation

Articles by Secrist, H.

Articles by Umetsu, D. T.

Pubmed/NCBI databases

Medline Plus Health Information
Substance via MeSH
Hay Fever

Social Bookmarking

What's this?

ARTICLES

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

H Secrist, CJ Chelen, Y Wen, JD Marshall and DT Umetsu
Department of Pediatrics, Stanford University, California 94305.

Allergen specific CD4+ T cell clones generated from allergic individuals have been shown to produce increased levels of the cytokine interleukin 4 (IL-4), compared to allergen specific clones generated from nonallergic individuals. This difference between CD4+ T cells from allergic and nonallergic individuals with regard to cytokine production in response to allergen is thought to be responsible for the development of allergic disease with increased IgE synthesis in atopic individuals. We examined the production of IL-4 in subjects with allergic rhinitis and in allergic individuals treated with allergen immunotherapy, a treatment which involves the subcutaneous administration of increasing doses of allergen and which is highly effective and beneficial for individuals with severe allergic rhinitis. We demonstrated that the quantity of IL-4 produced by allergen specific memory CD4+ T cells from allergic individuals could be considerably reduced by in vivo treatment with allergen (allergen immunotherapy). Immunotherapy reduced IL-4 production by allergen specific CD4+ T cells to levels observed with T cells from nonallergic subjects, or to levels induced with nonallergic antigens such as tetanus toxoid. In most cases the levels of IL-4 produced were inversely related to the length of time on immunotherapy. These observations indicate that immunotherapy accomplishes its clinical effects by reducing IL-4 synthesis in allergen specific CD4+ T cells. In addition, these observations indicate that the cytokine profiles of memory CD4+ T cells can indeed be altered by in vivo therapies. Thus, the cytokine profiles of memory CD4+ T cells are mutable, and are not fixed as had been suggested by studies of murine CD4+ memory T cells. Finally, treatment of allergic diseases with allergen immunotherapy may be a model for other diseases which may require therapies that alter inappropriate cytokine profiles of memory CD4+ T cells.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Dittrich, A. M., Chen, H.-C., Xu, L., Ranney, P., Connolly, S., Yarovinsky, T. O., Bottomly, H. K. (2008). A New Mechanism for Inhalational Priming: IL-4 Bypasses Innate Immune Signals. J. Immunol. 181: 7307-7315 [Abstract] [Full Text]
Gerstmayr, M., Ilk, N., Schabussova, I., Jahn-Schmid, B., Egelseer, E. M., Sleytr, U. B., Ebner, C., Bohle, B. (2007). A Novel Approach to Specific Allergy Treatment: The Recombinant Allergen-S-Layer Fusion Protein rSbsC-Bet v 1 Matures Dendritic Cells That Prime Th0/Th1 and IL-10-Producing Regulatory T Cells. J. Immunol. 179: 7270-7275 [Abstract] [Full Text]
Pilette, C., Nouri-Aria, K. T., Jacobson, M. R., Wilcock, L. K., Detry, B., Walker, S. M., Francis, J. N., Durham, S. R. (2007). Grass Pollen Immunotherapy Induces an Allergen-Specific IgA2 Antibody Response Associated with Mucosal TGF-beta Expression. J. Immunol. 178: 4658-4666 [Abstract] [Full Text]
van Oosterhout, A. J. M., Bloksma, N. (2005). Regulatory T-lymphocytes in asthma. Eur Respir J 26: 918-932 [Abstract] [Full Text]
Holm, J., Gajhede, M., Ferreras, M., Henriksen, A., Ipsen, H., Larsen, J. N., Lund, L., Jacobi, H., Millner, A., Wurtzen, P. A., Spangfort, M. D. (2004). Allergy Vaccine Engineering: Epitope Modulation of Recombinant Bet v 1 Reduces IgE Binding but Retains Protein Folding Pattern for Induction of Protective Blocking-Antibody Responses. J. Immunol. 173: 5258-5267 [Abstract] [Full Text]
Bohle, B., Breitwieser, A., Zwolfer, B., Jahn-Schmid, B., Sara, M., Sleytr, U. B., Ebner, C. (2004). A Novel Approach to Specific Allergy Treatment: The Recombinant Fusion Protein of a Bacterial Cell Surface (S-Layer) Protein and the Major Birch Pollen Allergen Bet v 1 (rSbsC-Bet v 1) Combines Reduced Allergenicity with Immunomodulating Capacity. J. Immunol. 172: 6642-6648 [Abstract] [Full Text]
Eisenbarth, S. C., Zhadkevich, A., Ranney, P., Herrick, C. A., Bottomly, K. (2004). IL-4-Dependent Th2 Collateral Priming to Inhaled Antigens Independent of Toll-Like Receptor 4 and Myeloid Differentiation Factor 88. J. Immunol. 172: 4527-4534 [Abstract] [Full Text]
Nouri-Aria, K. T., Wachholz, P. A., Francis, J. N., Jacobson, M. R., Walker, S. M., Wilcock, L. K., Staple, S. Q., Aalberse, R. C., Till, S. J., Durham, S. R. (2004). Grass Pollen Immunotherapy Induces Mucosal and Peripheral IL-10 Responses and Blocking IgG Activity. J. Immunol. 172: 3252-3259 [Abstract] [Full Text]
Jahn-Schmid, B., Kelemen, P., Himly, M., Bohle, B., Fischer, G., Ferreira, F., Ebner, C. (2002). The T Cell Response to Art v 1, the Major Mugwort Pollen Allergen, Is Dominated by One Epitope. J. Immunol. 169: 6005-6011 [Abstract] [Full Text]
Janssen, E. M., Wauben, M. H. M., Nijkamp, F. P., van Eden, W., van Oosterhout, A. J. M. (2002). Immunomodulatory Effects of Antigen-Pulsed Macrophages in a Murine Model of Allergic Asthma. Am. J. Respir. Cell Mol. Bio. 27: 257-264 [Abstract] [Full Text]
King, T. P., Jim, S. Y., Monsalve, R. I., Kagey-Sobotka, A., Lichtenstein, L. M., Spangfort, M. D. (2001). Recombinant Allergens with Reduced Allergenicity but Retaining Immunogenicity of the Natural Allergens: Hybrids of Yellow Jacket and Paper Wasp Venom Allergen Antigen 5s. J. Immunol. 166: 6057-6065 [Abstract] [Full Text]
Walter, D. M., Wong, C. P., DeKruyff, R. H., Berry, G. J., Levy, S., Umetsu, D. T. (2001). IL-18 Gene Transfer by Adenovirus Prevents the Development of and Reverses Established Allergen-Induced Airway Hyperreactivity. J. Immunol. 166: 6392-6398 [Abstract] [Full Text]
Leiva, L. E., Butler, B., Hempe, J., Ortigas, A. P., Sorensen, R. U. (2001). Up-Regulation of CD40 Ligand and Induction of a Th2 Response in Children Immunized with Pneumococcal Polysaccharide Vaccines. CVI 8: 233-240 [Abstract] [Full Text]
Jilek, S., Barbey, C., Spertini, F., Corthesy, B. (2001). Antigen-Independent Suppression of the Allergic Immune Response to Bee Venom Phospholipase A2 by DNA Vaccination in CBA/J Mice. J. Immunol. 166: 3612-3621 [Abstract] [Full Text]
Maecker, H. T., Hansen, G., Walter, D. M., DeKruyff, R. H., Levy, S., Umetsu, D. T. (2001). Vaccination with Allergen-IL-18 Fusion DNA Protects Against, and Reverses Established, Airway Hyperreactivity in a Murine Asthma Model. J. Immunol. 166: 959-965 [Abstract] [Full Text]
GREMBIALE, R. D., CAMPOROTA, L., NATY, S., TRANFA, C. M. E., DJUKANOVIC, R., MARSICO, S. A. (2000). Effects of Specific Immunotherapy in Allergic Rhinitic Individuals with Bronchial Hyperresponsiveness. Am. J. Respir. Crit. Care Med. 162: 2048-2052 [Abstract] [Full Text]
Vrtala, S., Akdis, C. A., Budak, F., Akdis, M., Blaser, K., Kraft, D., Valenta, R. (2000). T Cell Epitope-Containing Hypoallergenic Recombinant Fragments of the Major Birch Pollen Allergen, Bet v 1, Induce Blocking Antibodies. J. Immunol. 165: 6653-6659 [Abstract] [Full Text]
Brandenburg, A. H., de Waal, L., Timmerman, H. H., Hoogerhout, P., de Swart, R. L., Osterhaus, A. D. M. E. (2000). HLA Class I-Restricted Cytotoxic T-Cell Epitopes of the Respiratory Syncytial Virus Fusion Protein. J. Virol. 74: 10240-10244 [Abstract] [Full Text]
Astori, M., von Garnier, C., Kettner, A., Dufour, N., Corradin, G., Spertini, F. (2000). Inducing Tolerance by Intranasal Administration of Long Peptides in Naive and Primed CBA/J Mice. J. Immunol. 165: 3497-3505 [Abstract] [Full Text]
Korematsu, S., Tanaka, Y., Hosoi, S., Koyanagi, S., Yokota, T., Mikami, B., Minato, N. (2000). C8/119S Mutation of Major Mite Allergen Derf-2 Leads to Degenerate Secondary Structure and Molecular Polymerization and Induces Potent and Exclusive Th1 Cell Differentiation. J. Immunol. 165: 2895-2902 [Abstract] [Full Text]
Verhoef, A., Lamb, J. R. (2000). Threshold Signaling of Human Th0 Cells in Activation and Anergy: Modulation of Effector Function by Altered TCR Ligand. J. Immunol. 164: 6034-6040 [Abstract] [Full Text]
Bohle, B., Wagner, B., Vollmann, U., Buck, D., Niggemann, B., Szepfalusi, Z., Fischer, G., Scheiner, O., Breiteneder, H., Ebner, C. (2000). Characterization of T Cell Responses to Hev b 3, an Allergen Associated with Latex Allergy in Spina Bifida Patients. J. Immunol. 164: 4393-4398 [Abstract] [Full Text]
Janssen, E. M., van Oosterhout, A. J. M., van Rensen, A. J. M. L., van Eden, W., Nijkamp, F. P., Wauben, M. H. M. (2000). Modulation of Th2 Responses by Peptide Analogues in a Murine Model of Allergic Asthma: Amelioration or Deterioration of the Disease Process Depends on the Th1 or Th2 Skewing Characteristics of the Therapeutic Peptide. J. Immunol. 164: 580-588 [Abstract] [Full Text]
Kakinoki, Y., Ohashi, Y., Nakai, Y., Tanaka, A., Washio, Y. (2000). Pollen Immunotherapy Inhibits T Helper 1 and 2 Cell Responses, but Suppression of T Helper 2 Cell Response Is a More Important Mechanism Related to the Clinical Efficacy. Arch Otolaryngol Head Neck Surg 126: 63-70 [Abstract] [Full Text]
Hansen, G., Yeung, V. P., Berry, G., Umetsu, D. T., DeKruyff, R. H. (2000). Vaccination with Heat-Killed Listeria as Adjuvant Reverses Established Allergen-Induced Airway Hyperreactivity and Inflammation: Role of CD8+ T Cells and IL-18. J. Immunol. 164: 223-230 [Abstract] [Full Text]
Umetsu, D. T., DeKruyff, R. H. (1999). Interleukin-10 . The Missing Link in Asthma Regulation?. Am. J. Respir. Cell Mol. Bio. 21: 562-563 [Full Text]
Doyle, A. G., Buttigieg, K., Groves, P., Johnson, B. J., Kelso, A. (1999). The Activated Type 1-polarized CD8+ T Cell Population Isolated from an Effector Site Contains Cells with Flexible Cytokine Profiles. JEM 190: 1081-1092 [Abstract] [Full Text]
van Neerven, R. J. J., Wikborg, T., Lund, G., Jacobsen, B., Brinch-Nielsen, A., Arnved, J., Ipsen, H. (1999). Blocking Antibodies Induced by Specific Allergy Vaccination Prevent the Activation of CD4+ T Cells by Inhibiting Serum-IgE-Facilitated Allergen Presentation. J. Immunol. 163: 2944-2952 [Abstract] [Full Text]
Durham, S. R., Walker, S. M., Varga, E.-M., Jacobson, M. R., O'Brien, F., Noble, W., Till, S. J., Hamid, Q. A., Nouri-Aria, K. T. (1999). Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy. NEJM 341: 468-475 [Abstract] [Full Text]
Texier, C., Herve, M., Pouvelle, S., Menez, A., Maillere, B. (1999). On the diversity and heterogeneity of H-2d-restricted determinants and T cell epitopes from the major bee venom allergen. Int Immunol 11: 1313-1326 [Abstract] [Full Text]
BALL, T., FUCHS, T., SPERR, W. R., VALENT, P., VANGELISTA, L., KRAFT, D., VALENTA, R. (1999). B cell epitopes of the major timothy grass pollen allergen, Phl p 1, revealed by gene fragmentation as candidates for immunotherapy. FASEB J. 13: 1277-1290 [Abstract] [Full Text]
Yoshikawa, H., Nakajima, Y., Tasaka, K. (1999). Glucocorticoid Suppresses Autocrine Survival of Mast Cells by Inhibiting IL-4 Production and ICAM-1 Expression. J. Immunol. 162: 6162-6170 [Abstract] [Full Text]
AKDIS, C. A., BLASER, K. (1999). IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J. 13: 603-609 [Abstract] [Full Text]
Faith, A., Akdis, C. A., Akdis, M., Joss, A., Wymann, D., Blaser, K. (1999). An Altered Peptide Ligand Specifically Inhibits Th2 Cytokine Synthesis by Abrogating TCR Signaling. J. Immunol. 162: 1836-1842 [Abstract] [Full Text]
Yeung, V. P., Gieni, R. S., Umetsu, D. T., DeKruyff, R. H. (1998). Heat-Killed Listeria monocytogenes as an Adjuvant Converts Established Murine Th2-Dominated Immune Responses into Th1-Dominated Responses. J. Immunol. 161: 4146-4152 [Abstract] [Full Text]
Van Oosterhout, A. J.�M., Van Esch, B., Hofman, G., Hofstra, C. L., Van Ark, I., Nijkamp, F. P., Kapsenberg, M. L., Savelkoul, H. F.�J., Weller, F. R. (1998). Allergen Immunotherapy Inhibits Airway Eosinophilia and Hyperresponsiveness Associated with Decreased IL-4 Production by Lymphocytes in a Murine Model of Allergic Asthma. Am. J. Respir. Cell Mol. Bio. 19: 622-628 [Abstract] [Full Text]
Ferreira, F., Ebner, C., Kramer, B., Casari, G., Briza, P., Kungl, A. J., Grimm, R., Jahn-schmid, B., Breiteneder, H., Kraft, D., Breitenbach, M., Rheinberger, H.-j., Scheiner, O. (1998). Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J. 12: 231-242 [Abstract] [Full Text]